首页> 外文OA文献 >The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host

【2h】

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host

机译：基于修饰的痘苗病毒的重组疫苗的免疫原性表达非洲马疾病病毒VP2抗原的病毒取决于所表达的VP2蛋白递送给宿主的水平

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Eva Calvo-Pinilla; Simon Gubbins; Peter Mertens; Javier Ortego; Javier Castillo-Olivares;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host [J] . Calvo-Pinilla Eva, Gubbins Simon, Mertens Peter, Antiviral Research . 2018,第期

机译：基于修饰的痘苗病毒患者的重组疫苗的免疫原性表达非洲马病病毒VP2抗原的病毒取决于所表达的VP2蛋白递送给宿主的水平
2. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination [J] . Vaccine . 2017,第44期

机译：用重组改性的痘苗病毒疫苗接种疫苗（MVA）病毒表达单一非洲马疾病病毒VP2抗原诱导在组合施用时诱导马匹的交叉反应性病毒中和抗体（VNAB）
3. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge. [J] . Alberca B., Bachanek-Bankowska K., Cabana M., Vaccine . 2014,第29期

机译：用表达非洲马瘟（AHS）病毒主要衣壳蛋白VP2的重组修饰牛痘安卡拉病毒（MVA）接种马匹，可提供针对挑战的完整临床保护。
4. Protection induced by a recombinant replication-defective adenovirus vaccine expressing the P97 protein o￡ Mycoplasma byopneumoniae in challenged pigs: Comparison to Suvaxyn~R MH-one vaccine [C] . E R. Okamba, M. Arella, N. Music, Annual Meeting of the American Association of Swine Veterinarians . 2009

机译：通过重组复制缺陷的腺病毒疫苗诱导的保护，在挑战猪中表达P97蛋白O£opnoplasma opneumoniae：与Suvaxyn〜R MH-一疫苗相比
5. Effects of Modified Vaccinia Virus Ankara Expressing Mesothelin and the Poxvirus Immunoregulatory A35R gene in the Treatment of Murine Pancreatic Cancer [D] . Freistaedter, Andrew 2012

机译：表达间皮素和痘病毒免疫调节性A35R基因的痘苗病毒安卡拉对小鼠胰腺癌的治疗作用
6. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host [O] . Eva Calvo-Pinilla, Simon Gubbins, Peter Mertens, -1

机译：基于表达非洲马瘟病毒VP2抗原的改良痘苗安卡拉（MVA）病毒的重组疫苗的免疫原性取决于递送至宿主的VP2蛋白表达水平
7. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge [O] . Alberca Berta, Bachanek-Bankowska Katarzyna, Cabana Marta, 2014

机译：用表达非洲马瘟（AHS）病毒主要衣壳蛋白VP2的重组修饰牛痘安卡拉病毒（MVA）进行马匹疫苗接种，可提供针对挑战的完整临床保护

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host

著录项

引文网络

相似文献

相关主题

期刊订阅